標(biāo)題: Titlebook: Metastatic Bone Disease; An Integrated Approa R. Lor Randall Book 20161st edition Springer Science+Business Media New York 2016 Ablation te [打印本頁] 作者: hydroxyapatite 時間: 2025-3-21 17:43
書目名稱Metastatic Bone Disease影響因子(影響力)
書目名稱Metastatic Bone Disease影響因子(影響力)學(xué)科排名
書目名稱Metastatic Bone Disease網(wǎng)絡(luò)公開度
書目名稱Metastatic Bone Disease網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Metastatic Bone Disease被引頻次
書目名稱Metastatic Bone Disease被引頻次學(xué)科排名
書目名稱Metastatic Bone Disease年度引用
書目名稱Metastatic Bone Disease年度引用學(xué)科排名
書目名稱Metastatic Bone Disease讀者反饋
書目名稱Metastatic Bone Disease讀者反饋學(xué)科排名
作者: 描述 時間: 2025-3-21 23:48 作者: 防御 時間: 2025-3-22 01:29 作者: 免除責(zé)任 時間: 2025-3-22 06:42
hyperparathyroidism, both for the localisation of parathyroid pathology and as an aid to surgery. The introductory chapters review the basic core knowledge on the subject. Eighty case reviews are then presented, covering gamma camera planar imaging, SPECT, hybrid SPECT-CT, and also PET-CT. In total作者: 蝕刻術(shù) 時間: 2025-3-22 09:52
Antonella Chiechi MSc, PhD,Theresa A. Guise MDiation is sent to the disease areas, thus providing treatment, control, or pain palliation of the disease. Damages caused by ionized radiation such as single or double-strand breaks in cell DNA and DNA base changes play a role in the effectiveness of treatment. A therapeutic radiopharmaceutical is a作者: 下垂 時間: 2025-3-22 16:32 作者: Trypsin 時間: 2025-3-22 20:06
Sarah Colonna MD, BA,Theresa L. Werner MDped countries [1]. Most thyroid cancers are caused by follicular epithelium. These are papillary, follicular, Hurthle cell, and anaplastic thyroid cancers, respectively. More rarely medullary thyroid cancer (MTC) and lymphomas are observed. The first two of these, papillary and follicular type thyro作者: ALIAS 時間: 2025-3-22 23:26 作者: 充滿人 時間: 2025-3-23 03:39 作者: Expertise 時間: 2025-3-23 08:45
Patrik Luzny MD,Christopher Dechet MD, FACSiation is sent to the disease areas, thus providing treatment, control, or pain palliation of the disease. Damages caused by ionized radiation such as single or double-strand breaks in cell DNA and DNA base changes play a role in the effectiveness of treatment. A therapeutic radiopharmaceutical is a作者: 鼓掌 時間: 2025-3-23 11:04 作者: glomeruli 時間: 2025-3-23 17:10 作者: fiction 時間: 2025-3-23 19:10
ormation phase. During these two phases, several breakdown products of bone matrix including C-terminal or N-terminal telopeptide of type 1 collagen (CTX, NTX) and collagen crosslinks (deoxypyridinoline, pyridinoline) as well as components involved in bone formation such as collagen type 1 propeptid作者: 脫落 時間: 2025-3-23 23:57 作者: jaunty 時間: 2025-3-24 03:59 作者: 冷漠 時間: 2025-3-24 07:01 作者: 經(jīng)典 時間: 2025-3-24 14:00
Z. Deniz Olgun MD,Arianna Gianakos BSc,Jonathan E. Jo BS,Joseph M. Lane MDprimarily due to their favourable retention properties for metals, radionuclides and other contaminants. The retention properties result from various mineral phases in hydrated cement that possess a high density and diversity of reactive sites for the fixation of contaminants through a variety of so作者: Shuttle 時間: 2025-3-24 17:16 作者: 增長 時間: 2025-3-24 20:37
ope countries..At present the man-made transuranium elements created as a result of nuclear weapon tests or due to accidents on nuclear power plants are widely distributed on the surface of the Earth. Plutonium is the most widespread element among transuranium elements and is represented as alpha- a作者: Throttle 時間: 2025-3-25 01:34 作者: Rinne-Test 時間: 2025-3-25 06:50 作者: 忘恩負(fù)義的人 時間: 2025-3-25 11:12 作者: 減去 時間: 2025-3-25 14:22
Biology of Bone Cancer Painnts with skeletal metastases and is directly proportional to the patient’s quality of life, clinical advancements in the treatment of bone cancer pain are of the utmost importance. Research targeting pain-related cytokines, anti-osteoclastic medications, and ion channels has shown significant clinic作者: tattle 時間: 2025-3-25 17:26 作者: Petechiae 時間: 2025-3-25 21:35 作者: LITHE 時間: 2025-3-26 03:08
Lunge 4. At this point, there are no current options available with curative intent. However, options for treatment do exist. The advent of molecular testing has resulted in the determination of specific mutations, oncogenic drivers, that may be carried by primary lung cancer that provide intriguing tar作者: COW 時間: 2025-3-26 08:23
Kidney Metastatic Bone Diseases a spectrum of tumors that are significantly different with respect to their cell type origin and type of genetic mutations. Metastatic lesions are quite common in RCC. They are found in one third of new cases and develop in 20–40 % patients after surgical treatment for localized disease. Historica作者: TSH582 時間: 2025-3-26 12:26 作者: GRIPE 時間: 2025-3-26 13:44
Myelomasma cells in the bone marrow. Extramedullary disease, containing clusters of malignant plasma cells, occurs in some patients and is referred to as plasmacytoma. MM is preceded by an asymptomatic premalignant disorder, monoclonal gammopathy of undetermined significance (MGUS), in almost all patients.作者: 怕失去錢 時間: 2025-3-26 18:43 作者: 創(chuàng)新 時間: 2025-3-26 22:28
Biopsy Considerationsure. Even in a patient with a known history of metastatic carcinoma it is appropriate to obtain a biopsy to rule out other potential etiologies of osseous lesions. Failure to obtain a confirmatory biopsy creates the potential for errantly operating on a primary bone sarcoma, the consequences of whic作者: 擔(dān)憂 時間: 2025-3-27 03:50 作者: Mnemonics 時間: 2025-3-27 06:09
Biotargeting in Metastatic Bone Diseasend can cause significant disability for patients. In addition, many patients develop pathologic fractures which increase the risk of disability and lead to significant morbidity and mortality. Metastatic disease also puts patients at risk for hypercalcemia which can cause weakness, nausea, anorexia,作者: 殺蟲劑 時間: 2025-3-27 09:29
Psychosocial Considerations for Patients with Metastatic Bone Diseaseare services is the psychosocial needs of patients, families, and caregivers. Supportive care services are broad and best attended to with a multidisciplinary team approach that should include an oncology trained mental health provider. Patients with metastatic bone disease have a variety of needs p作者: justify 時間: 2025-3-27 17:39 作者: fluoroscopy 時間: 2025-3-27 19:51 作者: 睨視 時間: 2025-3-27 22:12
978-1-4939-7933-2Springer Science+Business Media New York 2016作者: CLASH 時間: 2025-3-28 04:11 作者: EWE 時間: 2025-3-28 09:11
https://doi.org/10.1007/978-1-4614-5662-9Ablation technologies; Biotargeting; Bisphosphonates; Bone cancer; Bone tumor; Cement augmentation; Interv作者: JOT 時間: 2025-3-28 14:06 作者: Etching 時間: 2025-3-28 16:13 作者: BARK 時間: 2025-3-28 21:17 作者: 推測 時間: 2025-3-29 01:02
Bisphosphonates, Denosumab, and Anabolic Agents in the Treatment of Metastatic Bone Diseasebisphosphonates and the more-recent arrival denosumab. This chapter summarizes the mechanisms of action and modes of use in metastatic bone treatment of these drugs, along with their side effects and how these may be addressed.作者: Hearten 時間: 2025-3-29 06:50
Biopsy Considerationsvaluation, enabling the determination of the tissue of origin and burden of skeletal disease. Regardless of whether the biopsy is performed in an open or percutaneous manner, the general principles of musculoskeletal biopsies are the same and must be respected for optimal patient outcome.作者: EPT 時間: 2025-3-29 10:21 作者: Femish 時間: 2025-3-29 12:10 作者: 和平 時間: 2025-3-29 17:55
Evaluation of the Patient with Carcinoma of Unknown Origin Metastatic to Bonefor carcinoma or to rule out primary bone sarcomas. Patients who present as a displaced pathologic fracture require an urgent diagnostic and treatment plan that does not compromise future treatment options and provides durable skeletal reconstruction.作者: constitute 時間: 2025-3-29 20:13 作者: Indebted 時間: 2025-3-30 01:28
Pathobiology of Osteolytic and Osteoblastic Bone Metastasess that result in abnormal bone destruction and/or formation. This complex bidirectional interplay between tumor cells and bone microenvironment establishes a “vicious cycle” that leads to a selective growth advantage for the cancer cells. The molecular insights gained on the underpinnings of bone me作者: 表主動 時間: 2025-3-30 05:26 作者: periodontitis 時間: 2025-3-30 08:42 作者: 載貨清單 時間: 2025-3-30 13:09
Myelomaover the past decade with the advent of novel biologic therapeutic agents, MM is considered an incurable disease. Risk adapted therapy with incorporation of novel agents is recommended for the initial treatment of MM with consideration for autologous hematopoietic stem cell transplantation in eligib作者: indicate 時間: 2025-3-30 17:09 作者: 四溢 時間: 2025-3-30 22:15 作者: HALO 時間: 2025-3-31 04:37
PET/CT) has been steadily growing and is now the preferred radionuclide imaging modality not only for identifying sites of lung infection but also for assessing the efficacy of therapy, especially in TB infection and in HIV-associated infections. PET/CT with [.F]FDG is also being increasingly used i作者: Isolate 時間: 2025-3-31 07:43 作者: crucial 時間: 2025-3-31 09:34
